The Myocarditis Foundation Welcomes Two New Members to Their Medical Advisory Board

The Myocarditis Foundation is pleased to announce the addition of two esteemed Cardiologists and Researchers to the Foundation’s Medical Advisory Board. Dr. Tang is with the Cleveland Clinic and Dr. Ammirati is with the DeGasperis Cardio Center and Transplant Center at the Niguarda Hospital in Milan, Italy.

Both Dr. Tang and Dr. Ammirati are extremely enthusiastic to participate in the Medical Advisory Board. We at the Myocarditis Foundation look forward to their scientific knowledge and expertise in the field of myocarditis. Please join us in welcoming Dr. Tang and Dr. Ammirati to the Foundation!

Dr. Wilson Tang, M.D.

Dr. Tang is Professor of Medicine at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University.  He received his M.D. degree from Harvard Medicine School, internal medicine residency training at Stanford University Medical Center, and cardiology fellowship training at the Cleveland Clinic.  He is a practicing heart failure and transplant cardiologist at the Cleveland Clinic’s Heart, Vascular and Thoracic Institute, specialized in cardiomyopathies and myocarditis, as well as kidney- and cancer-related heart diseases. As a clinician-scientist, Dr. Tang’s translational research focuses on understanding the cellular and molecular mechanisms that contribute to disease progression in heart failure and cardio-renal and inflammatory heart diseases, including some research work supported by the Myocarditis Foundation Postdoctoral Fellowship looking at the role of autoimmune mechanisms of myocarditis and dilated cardiomyopathy.  He has published over 650 peer-reviewed scientific manuscripts and book chapters, and has been elected as member of the American Society of Clinical Investigation in 2013 for his contributions to mechanistic understanding of cardio-renal syndromes, as well as the Association of American Physicians in 2018 for studying the contributing role of diet and microbiome in cardiovascular diseases.

 

Dr. Enrico Ammirati, M.D., PhD.

Dr. Ammirati is a clinical cardiologist who subspecializes in heart failure in Milano, Italy. He is an  attending physician at the De Gasperis Cardio Center and Transplant Center at the Niguarda Hospital in Milano, Italy, and Assistant Professor at the School of Medicine at the Vita-Salute San Raffaele University in Milano. Niguarda Hospital is one of the largest and important hospitals in all of Europe.

With a background in immunology and heart transplantation, he has developed an expertise in myocarditis and has published over 140 manuscripts, which include several manuscripts on myocarditis in major journals such as Circulation, Journal of American College of Cardiology and Lancet. He has systematically studied many patients with myocarditis, obtaining endomyocardial biopsy in patients with fulminant presentation, resulting in one of the largest cohort of patients with myocarditis and several important manuscripts that have re-defined how we approach these patients. For example, in a paper that was published in the Journal of American College of Cardiology (JACC) in the summer of 2019*, he studied the myocardial biopsies samples from 220 patients with myocarditis. These data have reinforced the critical role that direct myocardial tissue examination makes in patients with myocarditis.